Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Frank I Scott

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Overview 
    Collapse overview
    Frank I. Scott, MD, MSCE, is an expert in inflammatory bowel disease, with a particular interest in the risk-benefit balance of biologic and immunosuppressive therapies in Crohn's disease and ulcerative colitis. Dr. Scott received his undergraduate degree from the University of Pennsylvania and medical degree from Temple University in Philadelphia. After completing his internal medicine residency at Weill Cornell Medical Center, Dr. Scott returned to Philadelphia for his gastroenterology fellowship at the University of Pennsylvania, also completing an advanced fellowship in inflammatory bowel diseases in 2013 as well as a Masters' of Science in Clinical Epidemiology (MSCE). After several years on faculty at the University of Pennsylvania, Dr. Scott joined the faculty at the University of Colorado in Denver, Colorado in 2016.
    Dr. Scott is heavily invested in pharmacoepidemiologic research. His primary research interests include using quantitative and simulation-based methods to better understand the risk benefit balance and medication positioning in inflammatory bowel disease and how to best optimize the use of current therapies while reducing delays in care. He is also interested in exploring rare drug effects such as the association between antibiotic use and pediatric-onset obesity, and how the anti-fibrotic properties of HMG-coA reductase inhibitors, i.e. statins, may reduce the rates of adhesion-related and fibrostenotic complications after intra-abdominal surgery. He has significant experience in epidemiologic methods including decision analyses, Markov modeling, cost-effectiveness analysis, study design using large secondary and EMR-derived data, and disease risk and propensity score adjustment in such data. Over the course of his career, he has led or collaborated on research funded by the NIH, Crohn’s and Colitis Foundation, PCORI, and multiple industry partners.

    Collapse Research 
    Collapse research activities and funding
         (Frank I. Scott)Jan 1, 2019 - Jan 31, 2022
    Crohn's and Colitis Foundation
    Describing the Consequences of Delays in Biologic Therapy in IBD (DECODE-IBD)
    Role: PI

    K08DK095951     (SCOTT, FRANK IRVING)Sep 1, 2012 - Jun 30, 2019
    NIH
    Microvascular disease, statins, ACE-inhibitors and post-operative SBO
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jones B, Scott FI, Espinoza J, Laborde S, Chambers M, Wani S, Edmundowicz S, Austin G, Pell J, Patel SG. Leveraging electronic medical record functionality to capture adenoma detection rate. Sci Rep. 2022 Jun 11; 12(1):9679. PMID: 35690660.
      View in: PubMed
    2. Berlinberg AJ, Brar A, Stahly A, Gerich ME, Fennimore BP, Scott FI, Kuhn KA. A Novel Approach toward Less Invasive Multiomics Gut Analyses: a Pilot Study. Microbiol Spectr. 2022 Apr 27; 10(2):e0244621. PMID: 35343759.
      View in: PubMed
    3. Constant BD, de Zoeten EF, Stahl MG, Vajravelu RK, Lewis JD, Fennimore B, Gerich ME, Scott FI. Delays Related to Prior Authorization in Inflammatory Bowel Disease. Pediatrics. 2022 03 01; 149(3). PMID: 35190811.
      View in: PubMed
    4. Kim HS, Hernaez R, Sansgiry S, Waljee AK, Scott FI, Lewis JD, El-Serag HB, Hou JK. Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 Feb 28. PMID: 35240331.
      View in: PubMed
    5. Kolb JM, Chen M, Tavakkoli A, Singal AG, Vajravelu RK, Wani S. Understanding Compliance, Practice Patterns, and Barriers Among Gastroenterologists and Primary Care Providers Is Crucial for Developing Strategies to Improve Screening for Barrett's Esophagus. Gastroenterology. 2022 05; 162(6):1568-1573.e4. PMID: 35150724.
      View in: PubMed
    6. Almario CV, Kogan L, van Deen WK, Scott FI, Singh S, Hou JK, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar MC, Mize C, Ostrov A, Shah SA, Younes Z, Weaver SA, Heller C, Siegel CA, Melmed GY. Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 12 01; 116(12):2459-2464. PMID: 34730561.
      View in: PubMed
    7. Yen T, Scolaro J, Montminy E, Karlitz JJ, Wani S, Patel SG. Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50. Clin Gastroenterol Hepatol. 2021 Nov 18. PMID: 34800736.
      View in: PubMed
    8. Wang L, Scott FI, Boursi B, Reiss KA, Williams S, Glick H, Yang YX. Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes. Clin Gastroenterol Hepatol. 2021 Nov 02. PMID: 34737092.
      View in: PubMed
    9. Chu BK, Scott FI, Bewtra M. Optimal Placement of Colectomy in the Treatment of Ulcerative Colitis: a Markov Model Analysis. J Gastrointest Surg. 2021 12; 25(12):3208-3217. PMID: 34725785.
      View in: PubMed
    10. Haydek JP, Scott FI. Editorial: infliximab or adalimumab as first- or second-line anti-TNF-conflicting evidence. Aliment Pharmacol Ther. 2021 09; 54(6):846-847. PMID: 34425006.
      View in: PubMed
    11. Singh S, Proctor D, Scott FI, Falck-Ytter Y, Feuerstein JD. AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology. 2021 06; 160(7):2512-2556.e9. PMID: 34051985.
      View in: PubMed
    12. Lefferts AR, Regner EH, Stahly A, O'Rourke B, Gerich ME, Fennimore BP, Scott FI, Freeman AE, Jones K, Kuhn KA. Circulating mature granzyme B+ T cells distinguish Crohn's disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn's disease. Arthritis Res Ther. 2021 05 22; 23(1):147. PMID: 34022940.
      View in: PubMed
    13. Ahmed W, Scott FI. Closing the Gap: the Real-World Risk of Serious Infections With Vedolizumab in Comparison With Anti-TNF Therapy in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 02; 20(2):e28-e30. PMID: 34022455.
      View in: PubMed
    14. Han S, Kolb JM, Hosokawa P, Friedman C, Fox C, Scott FI, Lieu CH, Vajravelu RK, McCarter M, Murphy CC, Cook MB, Gleisner A, Falk GW, Katzka DA, Wani S. The Volume-Outcome Effect Calls for Centralization of Care in Esophageal Adenocarcinoma: Results From a Large National Cancer Registry. Am J Gastroenterol. 2021 04; 116(4):811-815. PMID: 33982952.
      View in: PubMed
    15. Berlinberg AJ, Regner EH, Stahly A, Brar A, Reisz JA, Gerich ME, Fennimore BP, Scott FI, Freeman AE, Kuhn KA. Multi 'Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway. Front Immunol. 2021; 12:587119. PMID: 33746944.
      View in: PubMed
    16. Vajravelu RK, Kolb JM, Thanawala SU, Scott FI, Han S, Singal AG, Falk GW, Katzka DA, Wani S. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2021 Feb 05. PMID: 33549872.
      View in: PubMed
    17. Scott FI, Vajravelu RK, Mamtani R, Bianchina N, Mahmoud N, Hou JK, Wu Q, Wang X, Haynes K, Lewis JD. Association Between Statin Use at the Time of Intra-abdominal Surgery and Postoperative Adhesion-Related Complications and Small-Bowel Obstruction. JAMA Netw Open. 2021 02 01; 4(2):e2036315. PMID: 33533930.
      View in: PubMed
    18. Osterman MT, Scott FI, Fogt FF, Gilroy ED, Parrott S, Galanko J, Cross R, Moss A, Herfarth HH, Higgins PDR. Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE). Inflamm Bowel Dis. 2021 01 19; 27(2):207-214. PMID: 32170946.
      View in: PubMed
    19. Kriss M, Te HS, Verna EC, VanWagner LB, Scott FI, Lai JC. National Early Career Transplant Hepatologist Survey: Compensation, Burnout, and Job Satisfaction. Hepatol Commun. 2021 04; 5(4):701-712. PMID: 33860127.
      View in: PubMed
    20. Scott FI, Hans AK, Gerich ME, Fennimore B, Mamtani R, Vajravelu RK, Lewis JD. Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's Disease. Clin Gastroenterol Hepatol. 2021 10; 19(10):2082-2092.e10. PMID: 32801006.
      View in: PubMed
    21. Kolb JM, Han S, Scott FI, Murphy CC, Hosokawa P, Wani S. Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older Individuals. Gastroenterology. 2020 12; 159(6):2238-2240.e4. PMID: 32777286.
      View in: PubMed
    22. Scott FI. Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch? Dig Dis Sci. 2020 08; 65(8):2158-2160. PMID: 32338328.
      View in: PubMed
    23. Vachon A, Scott FI. The treatment approach to inflammatory bowel disease in 2020. Curr Opin Gastroenterol. 2020 07; 36(4):247-256. PMID: 32452863.
      View in: PubMed
    24. Scott FI, Luo M, Shah Y, Lasch K, Vajravelu RK, Mamtani R, Fennimore B, Gerich ME, Lewis JD. Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis. J Crohns Colitis. 2020 Jun 19; 14(5):575-587. PMID: 31901085.
      View in: PubMed
    25. Mittal C, Dang D, Stoffel E, Menees S, Scott FI, Ahnen D, Patel SG. Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers. Dig Dis Sci. 2020 11; 65(11):3305-3315. PMID: 32500284.
      View in: PubMed
    26. Scott FI. Marijuana Use in Inflammatory Bowel Disease: Understanding the Prevalence and the Potential Pitfalls. Crohns Colitis 360. 2020 Apr; 2(2):otaa016. PMID: 32363340.
      View in: PubMed
    27. Vajravelu RK, Copelovitch L, Osterman MT, Scott FI, Mamtani R, Lewis JD, Denburg MR. Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age. Clin Gastroenterol Hepatol. 2020 09; 18(10):2262-2268. PMID: 31683056.
      View in: PubMed
    28. Johnson FR, Scott FI, Reed SD, Lewis JD, Bewtra M. Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations. Value Health. 2019 06; 22(6):684-692. PMID: 31198186.
      View in: PubMed
    29. Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Hurtado-Lorenzo A, Heller CA. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis. 2019 05 16; 25(Suppl 2):S40-S47. PMID: 31095704.
      View in: PubMed
    30. Bewtra M, Reed SD, Johnson FR, Scott FI, Gilroy E, Sandler RS, Chen W, Lewis JD. Variation Among Patients With Crohn's Disease in Benefit vs Risk Preferences and Remission Time Equivalents. Clin Gastroenterol Hepatol. 2020 02; 18(2):406-414.e7. PMID: 31100456.
      View in: PubMed
    31. Scott FI, Johnson FR, Bewtra M, Brensinger CM, Roy JA, Reed SD, Osterman MT, Mamtani R, Chen L, Yun H, Xie F, Curtis JR, Lewis JD. Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease. Inflamm Bowel Dis. 2019 04 11; 25(5):925-936. PMID: 30535149.
      View in: PubMed
    32. Kinnucan J, Binion D, Cross R, Evans E, Harlen K, Matarese L, Mullins A, O'Neal B, Reiss M, Scott FI, Weaver A, Rosenberg J. Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology. 2019 07; 157(1):242-254.e6. PMID: 30980795.
      View in: PubMed
    33. Scott FI, Singh S. Bridging Gaps in Evidence-based Clinical Practice in Inflammatory Bowel Diseases: Observational Comparative Effectiveness Research for the Win. Clin Gastroenterol Hepatol. 2019 08; 17(9):1726-1728. PMID: 30630101.
      View in: PubMed
    34. Hans AK, Scott FI. Editorial: which inflammatory bowel disease patients should be screened for Epstein-Barr virus infection? Aliment Pharmacol Ther. 2018 11; 48(10):1158-1159. PMID: 30375692.
      View in: PubMed
    35. Vajravelu RK, Mamtani R, Scott FI, Waxman A, Lewis JD. Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study. Gastroenterology. 2018 11; 155(5):1416-1427. PMID: 30056095.
      View in: PubMed
    36. Vajravelu RK, Scott FI, Mamtani R, Li H, Moore JH, Lewis JD. Medication class enrichment analysis: a novel algorithm to analyze multiple pharmacologic exposures simultaneously using electronic health record data. J Am Med Inform Assoc. 2018 07 01; 25(7):780-789. PMID: 29378062.
      View in: PubMed
    37. Han S, Brauer BC, Scott FI. A Heart-Stopping Cause of Upper Gastrointestinal Bleeding. Gastroenterology. 2018 10; 155(4):983-984. PMID: 29614298.
      View in: PubMed
    38. Scott FI, Lichtenstein GR. Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017. Curr Treat Options Gastroenterol. 2018 Mar; 16(1):147-164. PMID: 29492747.
      View in: PubMed
    39. Scott FI, Shah Y, Lasch K, Luo M, Lewis JD. Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model. Inflamm Bowel Dis. 2018 01 18; 24(2):286-295. PMID: 29361100.
      View in: PubMed
    40. Lewis JD, Scott FI, Brensinger CM, Roy JA, Osterman MT, Mamtani R, Bewtra M, Chen L, Yun H, Xie F, Curtis JR. Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-a-Directed Therapy for Inflammatory Bowel Disease. Am J Gastroenterol. 2018 03; 113(3):405-417. PMID: 29336432.
      View in: PubMed
    41. Vajravelu RK, Osterman MT, Aberra FN, Roy JA, Lichtenstein GR, Mamtani R, Goldberg DS, Lewis JD, Scott FI. Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization. Inflamm Bowel Dis. 2017 12 19; 24(1):217-226. PMID: 29272482.
      View in: PubMed
    42. Osterman CK, Alanzi J, Lewis JD, Kaufman EL, Narayan V, Boursi B, Vajravelu RK, Scott FI, Malkowicz SB, Mamtani R. Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer. Clin Genitourin Cancer. 2018 06; 16(3):235-239. PMID: 29287969.
      View in: PubMed
    43. Agarwal A, Garimall S, Scott FI, Ahmad NA, Kochman ML, Ginsberg GG, Chandrasekhara V. En bloc endoscopic mucosal resection is equally effective for sessile serrated polyps and conventional adenomas. Surg Endosc. 2018 04; 32(4):1871-1878. PMID: 28940106.
      View in: PubMed
    44. Scott FI, Mamtani R. Antibiotics and Obesity-A Burgeoning or Thinning Argument? JAMA Pediatr. 2017 02 01; 171(2):118-120. PMID: 28027341.
      View in: PubMed
    45. Mamtani R, Clark AS, Scott FI, Brensinger CM, Boursi B, Chen L, Xie F, Yun H, Osterman MT, Curtis JR, Lewis JD. Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study. Arthritis Rheumatol. 2016 10; 68(10):2403-11. PMID: 27159030.
      View in: PubMed
    46. Scott FI, Lichtenstein GR. Approach to the Patient with Mild Crohn's Disease: a 2016 Update. Curr Gastroenterol Rep. 2016 Sep; 18(9):50. PMID: 27448619.
      View in: PubMed
    47. Agarwal A, Scott FI, Ahmad NA, Chandrasekhara V. Chronic immunosuppression does not potentiate the malignant progression of mucinous pancreatic cystic lesions. Pancreatology. 2016 Sep-Oct; 16(5):900-4. PMID: 27424477.
      View in: PubMed
    48. Mamtani R, Lewis JD, Scott FI, Ahmad T, Goldberg DS, Datta J, Yang YX, Boursi B. Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study. PLoS Med. 2016 Apr; 13(4):e1002007. PMID: 27116322.
      View in: PubMed
    49. Shelton E, Laharie D, Scott FI, Mamtani R, Lewis JD, Colombel JF, Ananthakrishnan AN. Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. Gastroenterology. 2016 07; 151(1):97-109.e4. PMID: 27039969.
      View in: PubMed
    50. Scott FI, Horton DB, Mamtani R, Haynes K, Goldberg DS, Lee DY, Lewis JD. Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity. Gastroenterology. 2016 07; 151(1):120-129.e5. PMID: 27003602.
      View in: PubMed
    51. Scott FI, Lichtenstein GR. Advances in Therapeutic Drug Monitoring of Biologic Therapies in Inflammatory Bowel Disease: 2015 in Review. Curr Treat Options Gastroenterol. 2016 Mar; 14(1):91-102. PMID: 26847358.
      View in: PubMed
    52. Scott FI, Mamtani R, Haynes K, Goldberg DS, Mahmoud NN, Lewis JD. Validation of a coding algorithm for intra-abdominal surgeries and adhesion-related complications in an electronic medical records database. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):405-12. PMID: 26860870.
      View in: PubMed
    53. Horton DB, Scott FI, Haynes K, Putt ME, Rose CD, Lewis JD, Strom BL. Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study. JAMA Dermatol. 2016 Feb; 152(2):191-9. PMID: 26560335.
      View in: PubMed
    54. Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, Zhang J, Chen L, Xie F, Yun H, Osterman MT, Beukelman T, Margolis DJ, Curtis JR, Lewis JD. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer. JAMA Dermatol. 2016 Feb; 152(2):164-72. PMID: 26510126.
      View in: PubMed
    55. Mamtani R, Yang YX, Scott FI, Lewis JD, Boursi B. Association of Itraconazole, a Hedgehog Inhibitor, and Bladder Cancer. J Urol. 2016 08; 196(2):343-8. PMID: 26812305.
      View in: PubMed
    56. Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf. 2016 06; 25(6):628-36. PMID: 26710965.
      View in: PubMed
    57. Goldberg DS, French B, Lewis JD, Scott FI, Mamtani R, Gilroy R, Halpern SD, Abt PL. Liver transplant center variability in accepting organ offers and its impact on patient survival. J Hepatol. 2016 Apr; 64(4):843-51. PMID: 26626495.
      View in: PubMed
    58. Henao MP, Bewtra M, Osterman MT, Aberra FN, Scott FI, Lichtenstein GR, Kraschnewski J, Lewis JD. Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection. Inflamm Bowel Dis. 2015 Oct; 21(10):2262-71. PMID: 26193348.
      View in: PubMed
    59. Horton DB, Scott FI, Haynes K, Putt ME, Rose CD, Lewis JD, Strom BL. Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics. 2015 Aug; 136(2):e333-43. PMID: 26195533.
      View in: PubMed
    60. Scott FI, Osterman MT. Natalizumab for Crohn's Disease: Down but Not Out. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):1926-8. PMID: 26196443.
      View in: PubMed
    61. Mamtani R, Haynes K, Boursi B, Scott FI, Goldberg DS, Keefe SM, Vaughn DJ, Malkowicz SB, Lewis JD. Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):303-7. PMID: 25389114.
      View in: PubMed
    62. Agarwalla A, Small AJ, Mendelson AH, Scott FI, Kochman ML. Risk of recurrent or refractory strictures and outcome of endoscopic dilation for radiation-induced esophageal strictures. Surg Endosc. 2015 Jul; 29(7):1903-12. PMID: 25277484.
      View in: PubMed
    63. Mendelson AH, Small AJ, Agarwalla A, Scott FI, Kochman ML. Esophageal anastomotic strictures: outcomes of endoscopic dilation, risk of recurrence and refractory stenosis, and effect of foreign body removal. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):263-271.e1. PMID: 25019695.
      View in: PubMed
    64. Scott FI, Lichtenstein GR. Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2014 Mar; 12(1):59-75. PMID: 24452768.
      View in: PubMed
    65. Mamtani R, Haynes K, Finkelman BS, Scott FI, Lewis JD. Distinguishing incident and prevalent diabetes in an electronic medical records database. Pharmacoepidemiol Drug Saf. 2014 Feb; 23(2):111-8. PMID: 24375925.
      View in: PubMed
    66. Scott FI, Osterman MT, McConnell RA, Lorusso M, Aberra F, Kerner C, Lichtenstein GR, Lewis JD. Impact of JC virus antibody testing in patients with Crohn's disease with loss of response to infliximab: a Markov model. Inflamm Bowel Dis. 2013 Nov; 19(12):2625-33. PMID: 24108113.
      View in: PubMed
    67. Scott FI, Osterman MT. Medical management of crohn disease. Clin Colon Rectal Surg. 2013 Jun; 26(2):67-74. PMID: 24436652.
      View in: PubMed
    68. Scott FI, Osterman MT, Mahmoud NN, Lewis JD. Secular trends in small-bowel obstruction and adhesiolysis in the United States: 1988-2007. Am J Surg. 2012 Sep; 204(3):315-20. PMID: 22575399.
      View in: PubMed
    69. Scott FI, McConnell RA, Lewis ME, Lewis JD. Increasing complexity of clinical research in gastroenterology: implications for the training of clinician-scientists. Am J Gastroenterol. 2012 Apr; 107(4):496-500. PMID: 22475957.
      View in: PubMed
    70. Scott FI, Aberra F. VSL#3 for ulcerative colitis: growing evidence? Gastroenterology. 2011 May; 140(5):1685-6; discussion 1686-7. PMID: 21440588.
      View in: PubMed
    Scott's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)